MAPT and Alzheimer disease: To benchmark the phenotype of Tyrobp–/– mice against an AD phenotype, we compared hippocampal levels of total tau and Ser202/Thr205-phosphorylated tau between Tyrobp–/– and APP/PS1 mice, all 15 months old.